Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, February 14, 2011

Pantarhei to bid for Merck's Organon unit -report, (NYSE: MRK)

Dutch bioscience company Pantarhei intends to bid for the bulk of U.S. company Merck's (MRK.N) Netherlands-based bioscience research unit Organan, the Dutch Financieele Dagblad reported on Monday. Pantarhei Bioscience director Herjan Coeling Bennink, told the paper that Pantarhie can make the proposal as a result of backing from international private equity investors.No financial details were provided. The private equity investors were not named either. Merck said in September it had postponed the closure of Organon's R&D activities in the Netherlands while it negotiated on potential alternatives, including a sale. [ID:nLDE6810AB]

Source